Cargando…
The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter?
OBJECTIVE: To investigate the effect of pharmacological treatment of SpA on depressive symptoms and explore whether this effect differs between drug classes. METHODS: Data from the observational Assessment of SpondyloArthritis international Society Health Index Validation Study were used. Patients w...
Autores principales: | Webers, Casper, Kiltz, Uta, Braun, Jürgen, van der Heijde, Désirée, Boonen, Annelies |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234195/ https://www.ncbi.nlm.nih.gov/pubmed/36205588 http://dx.doi.org/10.1093/rheumatology/keac580 |
Ejemplares similares
-
Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)
por: Webers, Casper, et al.
Publicado: (2020) -
Development of one general and six country-specific algorithms to assess societal health utilities based on ASAS HI
por: Essers, Ivette, et al.
Publicado: (2019) -
Management of Axial Spondyloarthritis – Insights into Upadacitinib
por: Braun, Jürgen, et al.
Publicado: (2022) -
Impact of the COVID-19 pandemic on work productivity in patients with spondyloarthritis: results from the Dutch SpA-Net registry
por: Webers, Casper, et al.
Publicado: (2022) -
Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52‐Week, Randomized, Controlled Trial
por: Walsh, Jessica A., et al.
Publicado: (2022)